Página de resultados 11 para o Setor de Atividade: Saúde Ramo de Atividade: Biotecnologia Mercado de Ações - Cotações e Preços
Lista de todas as ações e títulos com preços, capitalizações de mercado, P/E (índice preço/lucro) e EPS (lucro por ação)
Todos os países
- {{country.name}}
- Todos os países
- Estados Unidos (1012)
- Austrália (58)
- Áustria (16)
- Bélgica (7)
- Brasil (16)
- Canadá (83)
- China (92)
- Dinamarca (6)
- Finlândia (4)
- França (41)
- Alemanha (738)
- Hong Kong (46)
- Índia (19)
- Irlanda (1)
- Israel (19)
- Itália (4)
- Japão (37)
- México (28)
- Países Baixos (3)
- Nova Zelândia (1)
- Noruega (14)
- Polônia (9)
- Rússia (2)
- Coreia do Sul (12)
- Espanha (4)
- Suécia (70)
- Suíça (11)
- Taiwan (67)
- Tailândia (2)
- Turquia (1)
- Reino Unido (69)
Todas as bolsas de valores
- {{item.name}}
- Todas as bolsas de valores
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (289)
- NasdaqGM (143)
- NasdaqGS (218)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (119)
- OTC Markets OTCPK (134)
- OTC Markets OTCQB (33)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (45)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
Saúde (2608)
- {{item.name}}
- Todos os setores
- Saúde (2608)
Biotecnologia (2608)
- {{item.name}}
- Todas as indústrias
- Biotecnologia (2608)
- Fabricantes de Medicamentos-Gerais (265)
- Fabricantes de Medicamentos-Especializados e Genéricos (1632)
- Planos de Assistência Médica (57)
- Instalações de Assistência Médica (554)
- Drogarias (155)
- Serviços de Informações de Saúde (419)
- Dispositivos Médicos (916)
- Instrumentos e Suprimentos Médicos (501)
- Diagnóstico e Pesquisa (429)
- Distribuição de Produtos Médicos (138)
| Nome Nome | Preço Preço |
24h% 7d Gráfico 24h% & 7d |
M.Cap Capitalização de Mercado | VOL Volume | Baixa 24h | Alta 24h | Capitalização de Mercado | Índice P/L | LPA |
|---|
| Nome Nome | Preço Preço |
24h% 7d Gráfico 24h% & 7d |
M.Cap Capitalização de Mercado | VOL Volume | Baixa 24h | Alta 24h | Capitalização de Mercado | Índice P/L | LPA | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Vertex Pharmaceuticals Incorporated VRTX.VI | $388.85 425.07 USD |
-0.52
|
$99.86B 109.16B USD | $0 0 USD | $388.85 425.07 USD | $388.85 425.07 USD | $99.86B 109.16B USD | 0 | -$3.32 -3.6 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $388.35 424.52 USD |
-1.22
|
$99.73B 109.02B USD | $3 3.28 USD | $388.35 424.52 USD | $388.35 424.52 USD | $99.73B 109.02B USD | 0 | -$3.26 -3.5 USD | |
| CSL CMXHF | $158.4 — |
-3.17
|
$78.94B — | $54 — | $151.5 — | $151.5 — | $78.94B — | 29.06 | $5.45 — | |
| CSL Limited CSJA.F | $66.5 72.69 USD |
+0.76
|
$65.6B 71.71B USD | $5 5.47 USD | $66.5 72.69 USD | $66.5 72.69 USD | $65.6B 71.71B USD | 28.29 | $2.35 2.57 USD | |
| CSL Limited CSJ.F | $133.7 146.15 USD |
+0.45
|
$65.4B 71.49B USD | $5 5.47 USD | $133.7 146.15 USD | $133.7 146.15 USD | $65.4B 71.49B USD | 28.38 | $4.71 5.15 USD | |
| Regeneron Pharmaceuticals, Inc. REGN34.SA | $48.78 9.89 USD |
+0.74
|
$316.57B 64.16B USD | $0 0 USD | $0 0 USD | $0 0 USD | $316.57B 64.16B USD | 13.32 | $3.66 0.74 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.MX | $9,875 584.72 USD |
0
|
$1.08T 63.91B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.08T 63.91B USD | 13.28 | $743.59 44.03 USD | |
| Samsung Biologics Co.,Ltd. 207940.KS | $1,010,000 762.38 USD |
-0.49
|
$71.89T 54.26B USD | $71.08K 53.65 USD | $1,006,000 759.37 USD | $1,024,000 772.95 USD | $71.89T 54.26B USD | 0 | $0 0 USD | |
| Regeneron Pharmaceuticals, Inc. REGN.VI | $450 491.91 USD |
-1.77
|
$47.99B 52.46B USD | $0 0 USD | $450 491.91 USD | $450 491.91 USD | $47.99B 52.46B USD | 13.21 | $34.04 37.21 USD | |
| Alnylam Pharmaceuticals, Inc. A1LN34.SA | $84.94 17.22 USD |
0
|
$222.49B 45.09B USD | $0 0 USD | $0 0 USD | $0 0 USD | $222.49B 45.09B USD | 0 | -$0.58 -0.1 USD | |
| Seagen Inc. S1GE34.SA | $56.7 11.49 USD |
0
|
$214.37B 43.45B USD | $0 0 USD | $0 0 USD | $0 0 USD | $214.37B 43.45B USD | 0 | $0 0 USD | |
| Seagen SGEN | $228.74 — |
0
|
$43.15B — | $0 — | $0 — | $0 — | $43.15B — | 0 | $0 — | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Seagen Inc. SGEN.MX | $3,711.48 219.77 USD |
0
|
$700.22B 41.46B USD | $0 0 USD | $0 0 USD | $0 0 USD | $700.22B 41.46B USD | 0 | $0 0 USD | |
| argenx SE A1RG34.SA | $126.1 25.56 USD |
-4.43
|
$192.49B 39.01B USD | $0 0 USD | $0 0 USD | $0 0 USD | $192.49B 39.01B USD | 36.34 | $3.47 0.7 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $263.7 288.26 USD |
-0.38
|
$34.73B 37.96B USD | $30 32.79 USD | $263.7 288.26 USD | $263.7 288.26 USD | $34.73B 37.96B USD | 0 | -$1.85 -2.02 USD | |
| argenx SE ARGNF | $562 — |
-4.18
|
$34.32B — | $10 — | $562 — | $562 — | $34.32B — | 34.22 | $16.42 — | |
| Bonus BioGroup BBIXF | $0.05 — |
+50899
|
$33.85B — | $20.03K — | $0.0002999 — | $0.0002999 — | $33.85B — | 0 | -$0.01 — | |
| UCB SA UCB.VI | $161.4 176.43 USD |
-0.71
|
$30.84B 33.72B USD | $0 0 USD | $161.4 176.43 USD | $161.4 176.43 USD | $30.84B 33.72B USD | 29.45 | $5.48 5.99 USD | |
| argenx SE ARGX.VI | $492.7 538.59 USD |
0
|
$30.69B 33.55B USD | $0 0 USD | $492.7 538.59 USD | $502 548.75 USD | $30.69B 33.55B USD | 34.72 | $14.19 15.51 USD | |
| UCB SA UNC.F | $160.5 175.45 USD |
-1.62
|
$30.56B 33.4B USD | $1 1.09 USD | $160.5 175.45 USD | $160.5 175.45 USD | $30.56B 33.4B USD | 28.86 | $5.56 6.08 USD | |
| UCB SA UNC0.F | $79 86.36 USD |
-1.86
|
$30.48B 33.32B USD | $50 54.66 USD | $79 86.36 USD | $79 86.36 USD | $30.48B 33.32B USD | 28.31 | $2.79 3.05 USD | |
| UCB SA UCBJF | $174.55 — |
-10.49
|
$33.17B — | $100 — | $174.55 — | $174.55 — | $33.17B — | 27.53 | $6.34 — | |
| argenx SE 1AE.F | $476 520.33 USD |
-2.86
|
$29.81B 32.59B USD | $2 2.19 USD | $476 520.33 USD | $476 520.33 USD | $29.81B 32.59B USD | 34.94 | $13.62 14.89 USD | |
| argenx SE 1AEA.F | $470 513.77 USD |
-3.29
|
$29.68B 32.44B USD | $5 5.47 USD | $470 513.77 USD | $470 513.77 USD | $29.68B 32.44B USD | 34.05 | $13.8 15.09 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.DE | $227.2 248.36 USD |
0
|
$27.27B 29.81B USD | $0 0 USD | $0 0 USD | $0 0 USD | $27.27B 29.81B USD | 0 | $0 0 USD | |
| BioNTech SE B1NT34.SA | $36.52 7.4 USD |
0
|
$141.84B 28.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $141.84B 28.75B USD | 0 | -$1.28 -0.2 USD | |
| BeOne Medicines Ltd. 49BA.F | $224 244.86 USD |
-2.61
|
$25.77B 28.17B USD | $15 16.4 USD | $224 244.86 USD | $224 244.86 USD | $25.77B 28.17B USD | 0 | -$3.08 -3.3 USD | |
| BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
+0.58
|
$25.73B 28.13B USD | $509 556.41 USD | $16.6 18.15 USD | $16.6 18.15 USD | $25.73B 28.13B USD | 0 | -$0.24 -0.2 USD | |
| Celltrion, Inc. 068270.KS | $161,800 122.13 USD |
0
|
$36.63T 27.65B USD | $369.84K 279.17 USD | $160,500 121.15 USD | $163,000 123.04 USD | $36.63T 27.65B USD | 0 | $0 0 USD | |
| BeiGene, Ltd. B1GN34.SA | $44.65 9.05 USD |
0
|
$123.42B 25.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $123.42B 25.02B USD | 0 | $0 0 USD | |
| BioNTech SE 22UA.F | $91.2 99.69 USD |
+0.05
|
$22.14B 24.21B USD | $6 6.56 USD | $91.2 99.69 USD | $91.6 100.13 USD | $22.14B 24.21B USD | 0 | -$3.18 -3.4 USD | |
| BioNTech SE BNTX.VI | $91.55 100.08 USD |
-0.87
|
$22.01B 24.06B USD | $311 339.97 USD | $91.55 100.08 USD | $92.05 100.62 USD | $22.01B 24.06B USD | 0 | -$3.19 -3.4 USD | |
| Genmab A/S GE9.DE | $331 361.83 USD |
0
|
$21.66B 23.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $21.66B 23.68B USD | 0 | $0 0 USD | |
| BeiGene BGNE | $184.72 — |
0
|
$20.21B — | $0 — | $0 — | $0 — | $20.21B — | 0 | $0 — | |
| Royalty Pharma plc RPD.MU | $29.94 32.73 USD |
+0.13
|
$17.11B 18.7B USD | $0 0 USD | $29.94 32.73 USD | $29.94 32.73 USD | $17.11B 18.7B USD | 14.18 | $2.11 2.31 USD | |
| Insmed Incorporated IM8N.F | $87 95.1 USD |
+2.35
|
$17.1B 18.69B USD | $124 135.55 USD | $87 95.1 USD | $87 95.1 USD | $17.1B 18.69B USD | 0 | -$5.27 -5.7 USD | |
| Royalty Pharma plc RPD.F | $29.55 32.3 USD |
-1.2
|
$16.88B 18.45B USD | $15 16.4 USD | $29.55 32.3 USD | $29.55 32.3 USD | $16.88B 18.45B USD | 14.00 | $2.11 2.31 USD | |
| Insmed Incorporated IM8N.SG | $86.5 94.56 USD |
+0.58
|
$16.8B 18.37B USD | $0 0 USD | $86.5 94.56 USD | $86.5 94.56 USD | $16.8B 18.37B USD | 0 | -$5.17 -5.6 USD | |
| BioMarin Pharmaceutical Inc. BMRN.MX | $1,480 87.63 USD |
0
|
$283.83B 16.81B USD | $0 0 USD | $1,480 87.63 USD | $1,480 87.63 USD | $283.83B 16.81B USD | 28.48 | $51.95 3.08 USD | |
| BioMarin Pharmaceutical Inc. BM8.DE | $81.02 88.57 USD |
0
|
$15.26B 16.68B USD | $0 0 USD | $0 0 USD | $0 0 USD | $15.26B 16.68B USD | 0 | $0 0 USD | |
| Innovent Biologics IVBXF | $10.08 — |
-0.51
|
$16.51B — | $100 — | $10.08 — | $10.08 — | $16.51B — | 0 | -$0.01 — | |
| Innovent Biologics, Inc. 6IB.F | $8.35 9.13 USD |
-4.02
|
$13.92B 15.22B USD | $100 109.31 USD | $8.2 8.96 USD | $8.55 9.35 USD | $13.92B 15.22B USD | 0 | -$0.01 -0.01 USD | |
| Incyte Corporation I1NC34.SA | $192.28 38.97 USD |
0
|
$74.44B 15.09B USD | $0 0 USD | $0 0 USD | $0 0 USD | $74.44B 15.09B USD | 343.35 | $0.56 0.11 USD | |
| Incyte Corporation INCY.MX | $1,306.32 77.35 USD |
0
|
$252.86B 14.97B USD | $0 0 USD | $0 0 USD | $0 0 USD | $252.86B 14.97B USD | 344.67 | $3.79 0.22 USD | |
| Sino Biopharmaceutical Limited SBMFF | $0.77 — |
+21.76
|
$13.76B — | $3.54K — | $0.77 — | $0.77 — | $13.76B — | 76.70 | $0.01 — | |
| WuXi Biologics (Cayman) WXIBF | $3.2 — |
+8.11
|
$13.69B — | $400 — | $3.2 — | $3.2 — | $13.69B — | 29.09 | $0.11 — | |
| Genmab A/S GMAB.VI | $197.4 215.78 USD |
+0.2
|
$12.2B 13.34B USD | $0 0 USD | $197.4 215.78 USD | $197.4 215.78 USD | $12.2B 13.34B USD | 13.37 | $14.76 16.13 USD | |
| Incyte Corporation ICY.F | $61.3 67.01 USD |
+1.49
|
$12.11B 13.24B USD | $1.36K 1.49K USD | $61.3 67.01 USD | $61.3 67.01 USD | $12.11B 13.24B USD | 340.55 | $0.18 0.2 USD | |
| Genmab A/S GNMSF | $207.75 — |
-7.38
|
$13.13B — | $84 — | $207.5 — | $207.85 — | $13.13B — | 12.19 | $17.04 — | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.6 6.12 USD |
-0.88
|
$11.79B 12.88B USD | $208 227.37 USD | $5.6 6.12 USD | $5.6 6.12 USD | $11.79B 12.88B USD | 32.94 | $0.17 0.19 USD | |
| Karuna Therapeutics KRTX | $329.83 — |
0
|
$12.6B — | $0 — | $0 — | $0 — | $12.6B — | 0 | $0 — | |
| Karuna Therapeutics, Inc. KRTX.MX | $3,226.17 191.03 USD |
0
|
$209.06B 12.38B USD | $0 0 USD | $0 0 USD | $0 0 USD | $209.06B 12.38B USD | 0 | $0 0 USD | |
| Sino Biopharmaceutical SBHMY | $9.75 — |
+2.85
|
$12.38B — | $44 — | $9.75 — | $9.75 — | $12.38B — | 33.62 | $0.29 — | |
| United Therapeutics Corporation UTH.F | $246.9 269.9 USD |
+0.04
|
$11.27B 12.32B USD | $41 44.82 USD | $246.9 269.9 USD | $246.9 269.9 USD | $11.27B 12.32B USD | 11.21 | $22.01 24.06 USD | |
| BioMarin Pharmaceutical Inc. B1MR34.SA | $155.27 31.47 USD |
-2.86
|
$59.73B 12.11B USD | $0 0 USD | $0 0 USD | $0 0 USD | $59.73B 12.11B USD | 21.35 | $7.27 1.47 USD | |
| Verona Pharma plc I9SA.F | $81.8 89.42 USD |
+3.54
|
$11.07B 12.1B USD | $38 41.54 USD | $77.6 84.83 USD | $81.8 89.42 USD | $11.07B 12.1B USD | 0 | -$1.67 -1.8 USD | |
| Ascendis Pharma A/S A1SN34.SA | $63.82 12.94 USD |
-0.41
|
$59.65B 12.09B USD | $0 0 USD | $0 0 USD | $0 0 USD | $59.65B 12.09B USD | 0 | -$37.17 -7.5 USD | |
| Moderna, Inc. MRNA.MX | $491.23 29.09 USD |
-1.75
|
$189.98B 11.25B USD | $6.54K 387.31 USD | $485 28.72 USD | $524.77 31.07 USD | $189.98B 11.25B USD | 0 | -$162 -9.5 USD | |
| Exelixis, Inc. EX9.F | $35.67 38.99 USD |
-0.03
|
$9.85B 10.77B USD | $30 32.79 USD | $35.67 38.99 USD | $35.67 38.99 USD | $9.85B 10.77B USD | 18.57 | $1.92 2.1 USD | |
| Ascendis Pharma A/S A71.F | $152 166.16 USD |
+3.4
|
$9.62B 10.52B USD | $1 1.09 USD | $152 166.16 USD | $152 166.16 USD | $9.62B 10.52B USD | 0 | -$5.92 -6.4 USD | |
| BioMarin Pharmaceutical Inc. BMRN.VI | $48.68 53.21 USD |
+0.75
|
$9.41B 10.28B USD | $151 165.06 USD | $48.42 52.93 USD | $48.68 53.21 USD | $9.41B 10.28B USD | 20.80 | $2.34 2.56 USD | |
| Akeso, Inc. 4RY.F | $10.2 11.15 USD |
-4.67
|
$9.33B 10.2B USD | $100 109.31 USD | $10.2 11.15 USD | $10.6 11.59 USD | $9.33B 10.2B USD | 0 | -$0.07 -0.07 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $48.35 52.85 USD |
-1.1
|
$9.27B 10.14B USD | $20 21.86 USD | $48.35 52.85 USD | $48.35 52.85 USD | $9.27B 10.14B USD | 20.75 | $2.33 2.55 USD | |
| Moderna, Inc. 0QF.F | $22.19 24.25 USD |
+0.84
|
$8.78B 9.6B USD | $2 2.19 USD | $22.13 24.19 USD | $22.19 24.25 USD | $8.78B 9.6B USD | 0 | -$7.18 -7.8 USD | |
| Moderna, Inc. MRNA.VI | $22.38 24.46 USD |
+0.65
|
$8.76B 9.58B USD | $156 170.53 USD | $22.38 24.46 USD | $22.42 24.5 USD | $8.76B 9.58B USD | 0 | -$7.56 -8.2 USD | |
| Moderna, Inc. 0QF.MU | $22.5 24.59 USD |
-3.12
|
$8.7B 9.51B USD | $0 0 USD | $22.5 24.59 USD | $22.5 24.59 USD | $8.7B 9.51B USD | 0 | -$7.42 -8.1 USD | |
| Bio-Techne Corporation T1CH34.SA | $9.29 1.88 USD |
-0.75
|
$44.91B 9.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $44.91B 9.1B USD | 61.93 | $0.15 0.03 USD | |
| Bio-Techne Corporation TECH.MX | $956.35 56.63 USD |
-34.9
|
$151.96B 9B USD | $0 0 USD | $0 0 USD | $0 0 USD | $151.96B 9B USD | 37.65 | $25.4 1.5 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen, Inc. IMGN.MX | $268.5 15.9 USD |
0
|
$149.06B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $149.06B 8.83B USD | 0 | $0 0 USD | |
| ImmunoGen IMGN | $31.23 — |
0
|
$8.72B — | $0 — | $0 — | $0 — | $8.72B — | 0 | $0 — | |
| Cerevel Therapeutics CERE | $44.96 — |
0
|
$8.19B — | $0 — | $0 — | $0 — | $8.19B — | 0 | $0 — | |
| Blueprint Medicines Corporation 2L9.F | $109 119.15 USD |
-3.2
|
$7.04B 7.7B USD | $135 147.57 USD | $109 119.15 USD | $109 119.15 USD | $7.04B 7.7B USD | 0 | -$2.24 -2.4 USD | |
| Bio-Techne Corporation TE1.F | $43.8 47.88 USD |
-0.45
|
$6.98B 7.63B USD | $50 54.66 USD | $43.8 47.88 USD | $43.8 47.88 USD | $6.98B 7.63B USD | 59.99 | $0.73 0.8 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $35.14 38.41 USD |
+2.78
|
$6.95B 7.6B USD | $35 38.26 USD | $35.14 38.41 USD | $35.14 38.41 USD | $6.95B 7.6B USD | 0 | -$3.12 -3.4 USD | |
| Halozyme Therapeutics, Inc. HALO.MX | $1,018.51 60.31 USD |
0
|
$125.64B 7.44B USD | $0 0 USD | $0 0 USD | $0 0 USD | $125.64B 7.44B USD | 14.34 | $70.99 4.2 USD | |
| Exelixis, Inc. EX9.DE | $21.09 23.05 USD |
0
|
$6.79B 7.42B USD | $0 0 USD | $0 0 USD | $0 0 USD | $6.79B 7.42B USD | 0 | $0 0 USD | |
| Corcept Therapeutics Incorporated HTD.F | $60.46 66.09 USD |
-0.95
|
$6.45B 7.05B USD | $11 12.02 USD | $60.46 66.09 USD | $60.46 66.09 USD | $6.45B 7.05B USD | 61.07 | $0.99 1.08 USD | |
| Roivant Sciences Ltd. 87S.F | $9.41 10.28 USD |
-2.24
|
$6.39B 6.99B USD | $600 655.88 USD | $9.41 10.28 USD | $9.42 10.3 USD | $6.39B 6.99B USD | 0 | -$0.65 -0.7 USD | |
| Revolution Medicines, Inc. 42Z.F | $34 37.17 USD |
-4.49
|
$6.33B 6.92B USD | $50 54.66 USD | $34 37.17 USD | $34 37.17 USD | $6.33B 6.92B USD | 0 | -$3.54 -3.8 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.55 20.28 USD |
-1.59
|
$6.31B 6.89B USD | $66 72.15 USD | $18.55 20.28 USD | $18.55 20.28 USD | $6.31B 6.89B USD | 0 | -$4.46 -4.8 USD | |
| Ionis Pharmaceuticals, Inc. IONS.MX | $647 38.31 USD |
0
|
$107B 6.34B USD | $0 0 USD | $0 0 USD | $0 0 USD | $107B 6.34B USD | 0 | -$56.47 -3.3 USD | |
| 3SBio Inc. 83B.F | $2.38 2.6 USD |
-3.25
|
$5.79B 6.33B USD | $3.97K 4.34K USD | $2.34 2.56 USD | $2.38 2.6 USD | $5.79B 6.33B USD | 23.80 | $0.1 0.11 USD | |
| Financière de Tubize SA FTD.SG | $127.2 139.05 USD |
-0.31
|
$5.78B 6.32B USD | $0 0 USD | $127.2 139.05 USD | $127.2 139.05 USD | $5.78B 6.32B USD | 63.60 | $2 2.19 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $46.42 50.74 USD |
-1.15
|
$5.72B 6.25B USD | $63 68.87 USD | $46.42 50.74 USD | $46.42 50.74 USD | $5.72B 6.25B USD | 14.37 | $3.23 3.53 USD | |
| Financière de Tubize SA FTD.F | $127.2 139.05 USD |
-1.55
|
$5.71B 6.24B USD | $70 76.52 USD | $127.2 139.05 USD | $127.2 139.05 USD | $5.71B 6.24B USD | 61.15 | $2.08 2.27 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $93.36 102.06 USD |
-1.6
|
$5.65B 6.18B USD | $7 7.65 USD | $93.34 102.03 USD | $93.36 102.06 USD | $5.65B 6.18B USD | 14.49 | $6.44 7.04 USD | |
| Legend Biotech Corporation 9LB.F | $30.6 33.45 USD |
-1.29
|
$5.64B 6.16B USD | $140 153.04 USD | $30.6 33.45 USD | $30.6 33.45 USD | $5.64B 6.16B USD | 0 | -$0.99 -1.08 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $243.3 265.96 USD |
-1.14
|
$5.42B 5.92B USD | $20 21.86 USD | $243.3 265.96 USD | $243.3 265.96 USD | $5.42B 5.92B USD | 0 | -$14.83 -16.2 USD | |
| ALK-Abelló A/S 4AJ0.F | $24.36 26.63 USD |
-0.57
|
$5.4B 5.9B USD | $50 54.66 USD | $24.36 26.63 USD | $24.36 26.63 USD | $5.4B 5.9B USD | 43.50 | $0.56 0.61 USD | |
| Abcam ABCM | $23.99 — |
0
|
$5.52B — | $0 — | $0 — | $0 — | $5.52B — | 0 | $0 — | |
| SK Biopharmaceuticals Co., Ltd. 326030.KS | $91,100 68.77 USD |
-0.87
|
$7.13T 5.39B USD | $133.23K 100.57 USD | $90,600 68.39 USD | $92,700 69.97 USD | $7.13T 5.39B USD | 0 | $0 0 USD | |
| ALK-Abelló A/S 0OIR.IL | $181.8 26.66 USD |
+21.65
|
$36.49B 5.35B USD | $82 12.02 USD | $181.8 26.66 USD | $182.1 26.7 USD | $36.49B 5.35B USD | 112.91 | $1.61 0.24 USD | |
| TG Therapeutics, Inc. NKB2.F | $30.45 33.28 USD |
-1.58
|
$4.83B 5.28B USD | $1.65K 1.8K USD | $30.45 33.28 USD | $30.45 33.28 USD | $4.83B 5.28B USD | 144.97 | $0.21 0.23 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $30.18 32.99 USD |
-1.5
|
$4.8B 5.25B USD | $235 256.89 USD | $30.18 32.99 USD | $30.18 32.99 USD | $4.8B 5.25B USD | 0 | -$2.6 -2.8 USD | |
| Biocon Limited BIOCON.BO | $356.3 4.31 USD |
-0.28
|
$426.87B 5.16B USD | $446.93K 5.41K USD | $353 4.27 USD | $364.65 4.41 USD | $426.87B 5.16B USD | 42.06 | $8.47 0.1 USD | |
| Abcam ABCZF | $22.25 — |
+0.68
|
$5.12B — | $4K — | $22.25 — | $22.25 — | $5.12B — | 2225.00 | $0.01 — | |
| ALK-Abelló A/S AKBLF | $22.35 — |
-17.19
|
$5.07B — | $100 — | $22.35 — | $22.35 — | $5.07B — | 34.38 | $0.65 — | |
|
Sem ações favoritas
Você ainda não possui ações favoritas. Por favor, adicione-as aos favoritos para vê-las aqui. |
||||||||||